Notice of Award of a Single-Source Cooperative Agreement To Fund Ghana Health Service, 6549-6550 [2022-02410]

Download as PDF lotter on DSK11XQN23PROD with NOTICES1 Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices objectives and eliminate unnecessary burden. Existing statutes specifically require the Board to coordinate with, and to rely to the fullest extent possible on work by the state insurance regulators. The Board and all state insurance regulators have entered into Memorandums of Understanding (MOU) allowing supervisors to freely exchange information relevant for the effective supervision of supervised insurance organizations. Federal Reserve examiners take the actions below with respect to state insurance regulators to support accomplishing the objective of minimizing supervisory duplication and burden, without sacrificing effective oversight: • Routine discussions with state insurance regulatory staff with greater frequency during times of stress; • Discussions around the annual supervisory plan, including how best to leverage work done by the state and potential participation by state insurance regulatory staff on relevant supervisory activities; • Consideration of the opinions and work done by the state when scoping relevant examination activities; • Documenting any input received from the state and consideration given to the opinions and work done by the state for relevant supervisory activities; • Sharing and discussing with the state the annual ratings and relevant conclusion documents from supervisory activities; • Collaboratively working with the states and the National Association of Insurance Commissioners (NAIC) on the development of policies that affect insurance depository institution holding companies; and • Participating in supervisory colleges. The Federal Reserve relies on the state insurance regulators to participate in the activities above and to share proactively their supervisory opinions and relevant documents. These documents include the annual Own Risk Solvency Assessment (ORSA),14 the state insurance regulator’s written assessment of the ORSA, results from its examination activities, the Corporate Governance Annual Disclosure, and other state supervisory material. If the Federal Reserve determines that it is necessary to perform supervisory activities related to aspects of the supervised insurance organization that also fall under the jurisdiction of the 14 Nat’l Ass’n of Ins. Comm’rs, Own Risk and Solvency Assessment (ORSA) Guidance Manual 9 (December 2017), https://www.naic.org/store/free/ ORSA_manual.pdf. VerDate Sep<11>2014 18:50 Feb 03, 2022 Jkt 256001 state insurance regulator, it will communicate the rationale and result of these activities to the state insurance regulator. By order of the Board of Governors of the Federal Reserve System. Ann Misback, Secretary of the Board. 6549 Montana, to acquire voting shares of Antler Land Company, and thereby indirectly acquire voting shares of Little Horn State Bank, both of Hardin, Montana. [FR Doc. 2022–02383 Filed 2–3–22; 8:45 am] Board of Governors of the Federal Reserve System, February 1, 2022. Michele Taylor Fennell, Deputy Associate Secretary of the Board. BILLING CODE 6210–01–P [FR Doc. 2022–02345 Filed 2–3–22; 8:45 am] BILLING CODE P FEDERAL RESERVE SYSTEM Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company The notificants listed below have applied under the Change in Bank Control Act (Act) (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank holding company. The factors that are considered in acting on the applications are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The public portions of the applications listed below, as well as other related filings required by the Board, if any, are available for immediate inspection at the Federal Reserve Bank(s) indicated below and at the offices of the Board of Governors. This information may also be obtained on an expedited basis, upon request, by contacting the appropriate Federal Reserve Bank and from the Board’s Freedom of Information Office at https://www.federalreserve.gov/foia/ request.htm. Interested persons may express their views in writing on the standards enumerated in paragraph 7 of the Act. Comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors, Ann E. Misback, Secretary of the Board, 20th Street and Constitution Avenue NW, Washington, DC 20551–0001, not later than February 22, 2022. A. Federal Reserve Bank of Minneapolis (Chris P. Wangen, Assistant Vice President), 90 Hennepin Avenue, Minneapolis, Minnesota 55480–0291. Comments can also be sent electronically to MA@mpls.frb.org: 1. Ascent BanCorp, Helena, Montana; Alan W. Bradley, Charles Shonkwiler, Christine A. N. Bradley, Kelcy Edwards, and certain minor children, all of Hamilton, Montana; Patrick Haffner, Frenchtown, Montana; Minott Pruyn, Daniel Schneiter, Haley Bradley, and a certain minor child, all of Missoula, Montana; and Daniel Wilcox, Corvallis, Montana; a group acting in concert with Bitterroot Holding Company, Lolo, PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Award of a Single-Source Cooperative Agreement To Fund Ghana Health Service Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $800,000, for Year 1 of funding to Ghana Health Service (GHS). Funding amounts for years 2–5 will be set at continuation. The award will build laboratory and Strategic Information (SI) capacity to improve the provision of HIV testing, treatment, and retention in line with HIV epidemic control and 95–95–95 targets (95% of HIV-positive individuals knowing their status, 95% of those receiving ART [Antiretroviral therapy], and 95% of those achieving viral suppression). DATES: The period for this award will be September 30, 2022 through September 29, 2027. FOR FURTHER INFORMATION CONTACT: Trong Ao, Center for Global Health, Centers for Disease Control and Prevention, CDC Ghana Office, U.S. Embassy, 24 Fourth Circular Road Cantonments, Accra, Ghana, Telephone: 800–232–6348, email: tfa8@cdc.gov. SUPPLEMENTARY INFORMATION: The single-source award will support the National AIDS Control Program of the GHS in the Ministry of Health to implement strategic information and laboratory strengthening activities in Ghana. GHS is a public service body established in 1996 under Act 525 as required by the 1992 Constitution of Ghana. GHS is in a unique position to conduct this work, as it is responsible for the implementation of national SUMMARY: E:\FR\FM\04FEN1.SGM 04FEN1 6550 Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices health policies under the control of Ministry of Health through the GHS Governing Council. GHS has the Mandate to provide and manage comprehensive and accessible health services with special emphasis on primary health care at regional, district, and sub-district levels. Summary of the Award Recipient: Ghana Health Service. Purpose of the Award: The purpose of this award is to build laboratory and SI capacity to improve the provision of HIV testing, treatment, and retention in line with HIV epidemic control and 95– 95–95 targets. This award strives to build and strengthen laboratories with the appropriate diagnostic technologies, trained and skilled staff, and systems that can provide efficient services. It also strengthens SI systems, data quality assurance, and the capacity of staff responsible for managing facility-based, survey, and surveillance data operating at national and subnational levels. Amount of Award: The approximate year 1 funding amount will be $800,000 in Federal Fiscal Year (FFY) 2022 funds, subject to the availability of funds. Funding amounts for years 2–5 will be set at continuation. Authority: This program is authorized under Public Law 108–25 (the United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act of 2003). Period of Performance: September 30, 2022 through September 29, 2027. Dated: February 1, 2022. Terrance Perry, Chief Grants Management Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–02410 Filed 2–3–22; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Award of a Single-Source Cooperative Agreement To Fund the National AIDS Control Program, Programme National de Lutte contre le VIH/SIDA (PNLS), Democratic Republic of Congo Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. lotter on DSK11XQN23PROD with NOTICES1 AGENCY: The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $500,000 for SUMMARY: VerDate Sep<11>2014 18:50 Feb 03, 2022 Jkt 256001 Year 1 of funding to the Programme National de Lutte contre le VIH/SIDA (PNLS). The award will strengthen Strategic Information (SI) activities, laboratory quality assurance services, and surveillance of new infections in Democratic Republic of Congo (DRC). This support will enhance the antiretroviral therapy (ART) cohort monitoring and delivery of HIV/AIDS services for the epidemic control in DRC. Funding amounts for years 2–5 will be set at continuation. DATES: The period for this award will be September 30, 2022 through September 29, 2027. FOR FURTHER INFORMATION CONTACT: Kaee Ross, Center for Global Health, Centers for Disease Control and Prevention, U.S. Embassy DRC, 498 Ave Col Lukusa, Kinshasa, Gombe, DRC, Telephone: 800–232–6348, email: knr6@ cdc.gov. SUPPLEMENTARY INFORMATION: The single-source award will improve data collection and analysis to produce a factual basis for evaluation and improvement of the HIV prevention, care, and treatment program in the DRC. The project will build capacity in DRC to have available, reliable data transmitted promptly for decisionmaking. Furthermore, the project will sustain quality assurance for rapid tests to ensure accuracy of results, and the monitoring of rapid tests used in the field. The PNLS is a specialized program run by the Ministry of Health (MOH) in the DRC. Created on August 5, 2015 by Ministerial Decision No. 449/MSLS/ CAB, the PNLS has been authorized and tasked to lead and coordinate the fight against the HIV/AIDS epidemic to achieve epidemic control. The PNLS is the governmental authority with the normative and regulatory role in the implementation of STI and HIV/AIDS control activities in the Health Zones (HZ). The PNLS has the authority to organize, review, and validate all data relative to HIV–AIDS in country. In addition, PNLS has the mission to control the quality of rapid test results provided by health care workers at facilities and to monitor how rapid tests are working in the field. Accordingly, PNLS has the sole authority and is uniquely qualified to perform the anticipated activities for this award. Summary of the Award Recipient: the Programme National de Lutte contre le VIH/SIDA (PNLS). Purpose of the Award: The purpose of this award is to strengthen SI activities, laboratory quality assurance services, and surveillance of new infections in PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 DRC. Support from this award will enhance ART cohort monitoring and delivery of HIV/AIDS services for control of the epidemic in DRC. Amount of Award: The approximate year 1 funding amount will be $500,000 in Federal Fiscal Year (FFY) 2022 funds, subject to the availability of funds. Funding amounts for years 2–5 will be set at continuation. Authority: This program is authorized under Public Law 108–25 (the United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act of 2003). Period of Performance: September 30, 2022 through September 29, 2027. Dated: February 1,2022. Terrance Perry, Chief Grants Management Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–02411 Filed 2–3–22; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Award of a Single-Source Cooperative Agreement To Fund the Sierra Leone Ministry of Health and Sanitation Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $450,000 for Year 1 of funding to the Sierra Leone (SL) Ministry of Health and Sanitation. The award will build laboratory and Strategic Information (SI) capacity to improve the provision of HIV testing, treatment, and retention in line with HIV epidemic control and 95–95– 95(95% of HIV-positive individuals knowing their status, 95% of those receiving ART [Antiretroviral therapy], and 95% of those achieving viral suppression) targets. Funding amounts for years 2–5 will be set at continuation. DATES: The period for this award will be September 30, 2022 through September 29, 2027. FOR FURTHER INFORMATION CONTACT: Trong Ao, Center for Global Health, Centers for Disease Control and Prevention, CDC Ghana Office, U.S. Embassy, 24 Fourth Circular Road Cantonments, Accra, Ghana, Telephone: 800–232–6348, Email: tfa8@cdc.gov. SUMMARY: E:\FR\FM\04FEN1.SGM 04FEN1

Agencies

[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Pages 6549-6550]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02410]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Award of a Single-Source Cooperative Agreement To Fund 
Ghana Health Service

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located 
within the Department of Health and Human Services (HHS), announces the 
award of approximately $800,000, for Year 1 of funding to Ghana Health 
Service (GHS). Funding amounts for years 2-5 will be set at 
continuation. The award will build laboratory and Strategic Information 
(SI) capacity to improve the provision of HIV testing, treatment, and 
retention in line with HIV epidemic control and 95-95-95 targets (95% 
of HIV-positive individuals knowing their status, 95% of those 
receiving ART [Antiretroviral therapy], and 95% of those achieving 
viral suppression).

DATES: The period for this award will be September 30, 2022 through 
September 29, 2027.

FOR FURTHER INFORMATION CONTACT: Trong Ao, Center for Global Health, 
Centers for Disease Control and Prevention, CDC Ghana Office, U.S. 
Embassy, 24 Fourth Circular Road Cantonments, Accra, Ghana, Telephone: 
800-232-6348, email: [email protected].

SUPPLEMENTARY INFORMATION: The single-source award will support the 
National AIDS Control Program of the GHS in the Ministry of Health to 
implement strategic information and laboratory strengthening activities 
in Ghana. GHS is a public service body established in 1996 under Act 
525 as required by the 1992 Constitution of Ghana. GHS is in a unique 
position to conduct this work, as it is responsible for the 
implementation of national

[[Page 6550]]

health policies under the control of Ministry of Health through the GHS 
Governing Council. GHS has the Mandate to provide and manage 
comprehensive and accessible health services with special emphasis on 
primary health care at regional, district, and sub-district levels.

Summary of the Award

    Recipient: Ghana Health Service.
    Purpose of the Award: The purpose of this award is to build 
laboratory and SI capacity to improve the provision of HIV testing, 
treatment, and retention in line with HIV epidemic control and 95-95-95 
targets. This award strives to build and strengthen laboratories with 
the appropriate diagnostic technologies, trained and skilled staff, and 
systems that can provide efficient services. It also strengthens SI 
systems, data quality assurance, and the capacity of staff responsible 
for managing facility-based, survey, and surveillance data operating at 
national and subnational levels.
    Amount of Award: The approximate year 1 funding amount will be 
$800,000 in Federal Fiscal Year (FFY) 2022 funds, subject to the 
availability of funds. Funding amounts for years 2-5 will be set at 
continuation.
    Authority: This program is authorized under Public Law 108-25 (the 
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act 
of 2003).
    Period of Performance: September 30, 2022 through September 29, 
2027.

    Dated: February 1, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-02410 Filed 2-3-22; 8:45 am]
BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.